Literature DB >> 11785684

Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.

Y Adachi1, H Suzuki, Y Sugiyama.   

Abstract

PURPOSE: MDR1 P-glycoprotein (P-gp) plays an important role in determining drug disposition. The purpose of the present study was to establish in vitro models to predict the in vivo function of P-gp.
METHODS: As an in vitro method, the transcellular transport of 12 compounds across the monolayer of Caco-2- and MDR1-transfected cells was examined. The ability of these compounds to stimulate the ATP hydrolysis was also determined using the isolated membrane fraction expressing P-gp. As a parameter to describe the in vivo P-gp function, we calculated the brain-to-plasma concentration ratio of compounds in mdr1a/1b knockout mice divided by the same ratio in wild type mice.
RESULTS: A good correlation was observed between the in vitro flux ratio across the monolayer and in vivo P-gp function for 12 compounds. Although all compounds that stimulated ATP hydrolysis were significantly transported by P-gp, some compounds were transported by P-gp without significantly affecting ATP hydrolysis.
CONCLUSION: Collectively, the in vitro flux ratio across monolayers of P-gp-expressing cells may be used to predict in vivo P-gp function. The extent of ATP-hydrolysis in vitro may also be a useful parameter for in vivo prediction, particularly for eliminating P-gp substrates in high-throughput screening procedures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785684     DOI: 10.1023/a:1013358126640

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 2.  Pharmacological insights from P-glycoprotein knockout mice.

Authors:  A H Schinkel
Journal:  Int J Clin Pharmacol Ther       Date:  1998-01       Impact factor: 1.366

3.  Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.

Authors:  M J Borgnia; G D Eytan; Y G Assaraf
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

4.  Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.

Authors:  J W Jonker; E Wagenaar; L van Deemter; R Gottschlich; H M Bender; J Dasenbrock; A H Schinkel
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results.

Authors:  M Yamazaki; W E Neway; T Ohe; I Chen; J F Rowe; J H Hochman; M Chiba; J H Lin
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

Review 6.  P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.

Authors:  M Verschraagen; C H Koks; J H Schellens; J H Beijnen
Journal:  Pharmacol Res       Date:  1999-10       Impact factor: 7.658

7.  Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery.

Authors:  L Z Benet; T Izumi; Y Zhang; J A Silverman; V J Wacher
Journal:  J Control Release       Date:  1999-11-01       Impact factor: 9.776

8.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

Authors:  U Mayer; E Wagenaar; B Dorobek; J H Beijnen; P Borst; A H Schinkel
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Characterization of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats.

Authors:  C F Neville; S Ninomiya; N Shimada; T Kamataki; S Imaoka; Y Funae
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

View more
  44 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

2.  Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition.

Authors:  J Cory Kalvass; Gary M Pollack
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

Review 3.  Current industrial practices of assessing permeability and P-glycoprotein interaction.

Authors:  Praveen V Balimane; Yong-Hae Han; Saeho Chong
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

Review 4.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

5.  Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat.

Authors:  Ken-ichi Umehara; Gian Camenisch
Journal:  Pharm Res       Date:  2011-10-20       Impact factor: 4.200

6.  Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells.

Authors:  Tomoko Watanabe; Reiko Onuki; Shinji Yamashita; Kazunari Taira; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

7.  Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.

Authors:  Dong-Hyun Choi; Joong-Hwa Chung; Jun-Shik Choi
Journal:  Eur J Clin Pharmacol       Date:  2009-12-12       Impact factor: 2.953

8.  Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs.

Authors:  T K Ritchie; Y V Grinkova; T H Bayburt; I G Denisov; J K Zolnerciks; W M Atkins; S G Sligar
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

9.  In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Christophe Rousselle; Marcel Debray; Jean-Michel Scherrmann
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

10.  Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier.

Authors:  Rong Zhao; Thomas J Raub; Geri A Sawada; Steven C Kasper; James A Bacon; Arlene S Bridges; Gary M Pollack
Journal:  Drug Metab Dispos       Date:  2009-03-09       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.